Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: Use of Fresh Platelet Rich Plasma With Concentrated Leukocytes or Fresh Platelet Rich Plasma Without Concentrated Leukocytes in the Treatment of Knee Cartilage Degeneration: a Randomized Controlled Trial [NA]
This randomized controlled trial evaluates fresh platelet-rich plasma with or without concentrated leukocytes for knee cartilage degeneratio…
-
CLINICAL_TRIALS research · 2025-01-01Clinical Trial Update: Vivacit-E Post-market Follow-up Study [NA]
This document reports that the Vivacit-E post-market follow-up study is currently active but not recruiting, evaluating osteoarthritis, avas…
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: MDR - Longevity IT Oblique and Offset Liners
Zimmer Biomet-sponsored trial NCT05980234 evaluating MDR Longevity IT Oblique and Offset Liners for hip-related conditions was terminated; d…
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: Patients' Perceptions of Assessment and Treatment of Knee Osteoarthritis in Primary Care
This clinical trial update describes patients' perceptions of how knee osteoarthritis is assessed and treated in primary care within the Vas…
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella
The PMCF study evaluating the safety, performance and clinical benefits data of the NexGen TM Augmentation Patella has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Predictive Model for 1-Year Pain and Function Outcomes After Thumb Joint Surgery in Osteoarthritic Patients
This entry provides an update on a clinical trial that aims to develop a predictive model for 1-year pain and function after thumb joint sur…
-
FDA approval · 2024-12-19FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA supplemental approval for Aurobindo Pharma Limited's generic celecoxib.
-
CLINICAL_TRIALS trial_result · 2024-12-16Clinical Trial Update: Continuum™ Metal Bearing System in Total Hip Arthroplasty
The Continuum Metal Bearing System for total hip arthroplasty completed its clinical trial and posted results.
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study [NA]
This Clinical Trial Update describes a post-marketing, multi-centre surveillance study of the AMIStem Primary Hip System sponsored by Medact…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Digital Osteoarthritis Care [NA]
An update on a clinical trial evaluating digital osteoarthritis care sponsored by Diakonhjemmet Hospital. The study is currently active but …
-
CLINICAL_TRIALS other · 2024-12-11Clinical Trial Update: A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis [Phase 2]
This clinical trial update notes a Phase 2 study to evaluate the safety and efficacy of TG-C in subjects with symptomatic early hip osteoart…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: ARVIS TKA vs Conventional TKA [NA]
The trial compares ARVIS TKA versus conventional total knee arthroplasty in osteoarthritis and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Pilot Study Evaluating the Safety and Efficacy of a New Hard-on-Hard Total Hip Replacement System [NA]
A pilot study evaluating the safety and effectiveness of a new hard-on-hard total hip replacement system has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: NexGen TM Tibia Clinical Outcomes Study [NA]
Results from the NexGen tibia clinical outcomes study have been posted after completion, evaluating outcomes across osteoarthritis and relat…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis [NA]
The first-in-human study of SakuraBead for genicular artery embolization to treat pain from knee osteoarthritis has been completed.
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Ultrasound-guided Injection of Glucocorticoid Into Infrapatellar Fat Pad in Patients With Knee Osteoarthritis [Phase 4]
A Phase 4 clinical trial investigating ultrasound-guided glucocorticoid injections into the infrapatellar fat pad for knee osteoarthritis ha…
-
FDA approval · 2024-12-03FDA Approved: ZILRETTA — Supplemental Application (Pacira Pharmaceuticals, Inc.)
FDA approves a supplemental application for ZILRETTA, an extended-release intra-articular corticosteroid, submitted by Pacira Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2024-12-02Clinical Trial Update: Comparing Exercise Programs for Managing Knee Osteoarthritis [NA]
This clinical trial update notes the completion of a study comparing exercise programs for managing knee osteoarthritis.
-
CLINICAL_TRIALS research · 2024-12-02Clinical Trial Update: Denervation for Osteoarthritis in the PIP-joint Efficacy Study (DOPS) [NA]
Karolinska Institutet is conducting a clinical trial to evaluate denervation for osteoarthritis of the finger's proximal interphalangeal joi…
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: A Study on Different Treatments for Knee Osteoarthritis Caused by Damaged Roots of the Medial Meniscus.
This clinical trial investigates several treatments for knee osteoarthritis caused by a damaged medial meniscus root, and is currently not r…
-
FDA approval · 2024-11-22FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s supplemental application for Naproxen and Esomeprazole Magnesium (ANDA 213699), establishing a generic…
-
FDA approval · 2024-11-22FDA Approved: RELAFEN DS — Supplemental Application (Carwin Pharmaceutical Associates, LLC)
The FDA approved a supplemental application for Relafen DS (nabumetone) submitted by Carwin Pharmaceutical Associates, LLC.
-
FDA approval · 2024-11-22FDA Approved: ETODOLAC — Supplemental Application (Ipca Laboratories Limited)
The FDA approved a supplemental application for etodolac filed by Ipca Laboratories Limited. This represents regulatory clearance for this g…
-
CLINICAL_TRIALS trial_result · 2024-11-22Clinical Trial Update: Study to Investigate the Mechanism of Action of an Oral Enzyme Treatment With Bromelain, Trypsin and Rutoside Versus Placebo in Subjects With OsTeoarthritis [NA]
An clinical trial evaluated the mechanism of action of an oral enzyme treatment consisting of bromelain, trypsin, and rutoside versus placeb…
-
FDA approval · 2024-11-21FDA Approved: NABUMETONE — Supplemental Application (Exelan Pharmaceuticals Inc.)
FDA approved a supplemental application for Nabumetone from Exelan Pharmaceuticals Inc., effectively updating its labeling under an existing…